414 filings
Page 2 of 21
8-K
b0vmjy1ej24pfa nocp6
15 Jun 23
Other Events
4:57pm
424B5
n9tua86m2 020ok78f
15 Jun 23
Prospectus supplement for primary offering
4:54pm
8-K
nqo2ir0a
12 Jun 23
Submission of Matters to a Vote of Security Holders
4:36pm
EFFECT
5x1z0r
30 May 23
Notice of effectiveness
12:15am
CORRESP
anz8jbfvkzg5bridsb
24 May 23
Correspondence with SEC
12:00am
UPLOAD
bpqxe6pcz1
19 May 23
Letter from SEC
12:00am
8-K
xr12ebac82iscy5
15 May 23
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:00am
8-K
xiwj vi9q
24 Apr 23
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
8:13am
8-K
c624fa6llz7nc2ua
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
c61rg1m1e65hb
4 Apr 23
Other Events
8:30am
8-K
ecjm h5ykr01
15 Mar 23
Regulation FD Disclosure
4:23pm
8-K
s4rvv
9 Jan 23
Regulation FD Disclosure
8:00am
8-K
gdt0el
26 Oct 22
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
8:00am